RETHINKING Alzheimer’s disease
Communication Toolkit

To help us spread the word about the launch of the RETHINKING Alzheimer’s disease project, we have created for you a communication toolkit that we invite you to share on your social media networks.

The toolkit includes a few pre-drafted social media posts and the direct links to download the visuals, please feel free to adapt the text to your own communication style. 

When publishing the post on social media, you can tag @EU_Brain, @EFPIA on Twitter and/or @European Brain Council,  @EFPIA – European Federation of Pharmaceutical Industries and Associations on LinkedIn.

We will be grateful for your help in communication and dissemination of the RETHINKING Alzheimer’s disease project. Please do not hesitate to get in touch with us if you need additional graphic sizes, formats or more information, you can contact us at comm@braincouncil.eu.

RETHINKING Alzheimer’s disease – Project launch

RETHINKING Alzheimer’s disease is a research-driven project, led by EBC and EFPIA, offering policy recommendations to make tangible changes with the aim to improve the lives of people living with Alzheimer’s disease (AD) across Europe.

Suggested tweet:

📢The RETHINKING #Alzheimer’s disease project, calling for change in AD care, has started its journey!

@EU_Brain & @EFPIA will work together to face the ambitious challenge of improving care pathway to improve the lives of people living with #AD.

🔎 bit.ly/3yEPXby

Suggested LinkedIn post:

📢 The RETHINKING #Alzheimer’s disease project, calling for change in AD care, has started its journey!
 
The European Brain Council & EFPIA – European Federation of Pharmaceutical Industries and Associations will work together to face the ambitious challenge of improving care pathway to improve the lives of people living with #AD.

🔎 Read more here: bit.ly/3yEPXby

RETHINKING Alzheimer’s disease – Focus areas

Building on the outcomes of the paper on “Alzheimer’s Disease Health System Readiness – The Time to Act is Now”, launched by EFPIA in 2020, the recommendations will focus on 4 areas: detection, diagnosis, AD interventions and treatment and monitoring.

Suggested tweet:

Building on the outcomes of the paper on “Alzheimer’s Disease Health System Readiness – The Time to Act is Now”, launched by @EFPIA, the RETHINKING #AD project will focus on:
 
🔦 detection
👨‍⚕️ diagnosis
🏥 AD interventions and treatment
🔎 monitoring
 
➡️ bit.ly/3wwyNtX

Suggested LinkedIn post:

Building on the outcomes of the paper on “Alzheimer’s Disease Health System Readiness – The Time to Act is Now”, launched by EFPIA – European Federation of Pharmaceutical Industries and Associations in 2020, the RETHINKING #Alzheimer’s disease project will focus on 4 areas:
 
🔦 detection
👨‍⚕️ diagnosis
🏥 AD interventions and treatment
🔎 monitoring
 
More info here ➡️ bit.ly/3wwyNtX

RETHINKING Alzheimer’s disease – Prevalence

It is estimated that 9.7 million people in Europe alone already live with Alzheimer’s disease and dementia. With a rapidly ageing population, it is a growing public health concern worldwide as this number is projected to rise to a staggering 14 million by 2030.

Suggested tweet:

📢 It is estimated that 9.7 million people in Europe live with #Alzheimer’s disease & #dementia.
 
Now is the time to rethink Alzheimer’s and respond to the challenge it poses on our society.
 
Learn more about the RETHINKING AD project 👉bit.ly/3wwyNtX

Suggested LinkedIn post:

📢 It is estimated that 9.7 million people in Europe alone already live with #Alzheimer’s disease and #dementia.

Now is the time to rethink Alzheimer’s and respond to the challenge it poses on our society.

Learn more about the RETHINKING Alzheimer’s disease project 👉 bit.ly/3wwyNtX